Federal Supply Schedule 36F79723D045E
Award Date
7/4/23
Last Date to Order
12/31/23
Federal Agency
Veterans Integrated Service Network 12
Awardee
Acer Therapeutics Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Acerus Pharmaceuticals Corporation. The contract, valued up to $750,000.00, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS Schedule 65 I B. The contract has a period of performance from May 15, 2021, to May 14, 2026.
As an FSS contract, this is a multiple-award vehicle that provides federal agencies with a streamlined purchasing process to...
The key points of this federal contract IDV award are as follows:
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract was awarded to Acer Therapeutics Inc. on January 1, 2024 and has a ceiling value of $225,000.00. The contract is for the procurement of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a period of performance lasting until December...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Acertis Pharmaceuticals LLC, a for-profit limited liability company that manufactures goods. The $25,000.00 contract is an interim agreement under FSS Schedule 65 I B, which covers drugs, pharmaceuticals, and hematology-related products. It has a period of performance ending on September 28, 2023. The contract does not use any set-asides and is a...
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Bioxcel Therapeutics, Inc. The contract has a ceiling value of $25,000.00 and a period of performance through February 14, 2023.
The contract is for an "Interim Agreement under FSS Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products." This indicates the contract provides for the delivery of pharmaceutical and related...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through May 14, 2025. As a Federal Supply Schedule contract, this is a multiple award...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Ars Pharmaceutical Operations, Inc. The $1,025,000.00 contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 I B. The contract has a period of performance from September 15, 2024 to March 14, 2025 and was set up as a multiple award vehicle with no set-asides. As an FSS contract, the awarded prime...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract, valued at a ceiling of $300,000.00, was awarded to Yaral Pharma Inc., a for-profit manufacturer, for a period of performance ending on April 30, 2028.
The contract falls under Schedule 65 I B, "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS", and is intended to provide the agency...
The Federal Supply Schedule (FSS) contract 36F79720D0115 was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Secura Bio, Inc., a for-profit manufacturer, on April 1, 2020. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) Master Schedule and has a ceiling value of $250,000.00. It is a multiple award contract with no set-asides, and the period of performance runs through September 30, 2025.
The purpose of the contract is to provide drugs,...
The Federal Supply Schedule (FSS) contract 36F79724D037E was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Day One Biopharmaceuticals, Inc. on June 3, 2024. The contract is a multiple award under Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products, with a ceiling value of $25,000.00 and a period of performance through November 30, 2024.
The purpose of this FSS contract is to provide the VISN 12 agency with interim...
This is a Federal Supply Schedule (FSS) contract awarded to Assertio Therapeutics Inc. by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract is for the procurement of pharmaceuticals, drugs, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) GSA schedule.
The contract has a ceiling value of $51,322,640.00 and a period of performance from July 1, 2020 to June 30, 2025. As a multiple...